News Focus
News Focus
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: genisi post# 2059

Wednesday, 10/07/2009 3:46:53 PM

Wednesday, October 07, 2009 3:46:53 PM

Post# of 3595
PreCISe data published in the Lancet

http://podcast.thelancet.com/audio/lancet/2009/07october.mp3

PreCISe study and multiple sclerosis

Encouraging results from a phase III placebo-controlled trial suggest that glatiramer acetate (already licensed for relapsing-remitting multiple sclerosis) is effective in reducing progression to clinically definite disease after a first clinically isolated syndrome. Individuals were studied for three years, with MRI analysis done every 3 months to compare underlying disease progression with clinical symptoms. The study is discussed in a podcast.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61259-9/fulltext

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TEVA News